Executive Moves: Riverside Oral Surgery, PHHCNS and more

Executive Moves is an occasional feature on ROI-NJ.com describing some of the important personnel changes in the New Jersey business community. Reports are based on news releases, edited for content, clarity and style.

Jeffrey DeBellis, Riverside Oral Surgery

Riverside Oral Surgery, the official oral surgeons of the New Jersey Devils, announces the hiring of Jeffrey DeBellis as its new chief operating officer. DeBellis brings 24 years of experience in health care to the role, and will be working directly with Riverside’s founder, managing partner, and Instagram’s BloodyToothGuy, Dr. Jason M. Auerbach, as well as Riverside’s medical director, Dr. Sung Hee Cho, surgeons and senior leadership team. Riverside now has locations in River Edge, Westwood, Englewood, Livingston, Chatham and Edison.

DeBellis comes to Riverside Oral Surgery most recently from Professional Physical Therapy, where he held the position of partner and vice president of New Jersey clinical operations. In this role, DeBellis was responsible for day-to-day management of 60 of Professional’s 200 outpatient clinics, worked directly with a 12-person regional management team across all organizational functions, and execution of the company’s growth strategy.

“I am thrilled to have been provided the opportunity to join the exceptional team of surgeons, managers and support staff here at Riverside Oral Surgery as COO. Riverside has a rich history of superior clinical outcomes, unrivaled patient experience, and an amazing team-oriented culture. I look forward to building upon the organization’s history of success,” DeBellis said.

Marianne Murawski, Preferred Home Health Care & Nursing Services

Marianne Murawski of Mount Laurel has been promoted to director of operations for Preferred Home Health Care & Nursing Services, Eatontown, with offices in New Jersey, Pennsylvania and Delaware.

As director of operations, Murawski will manage all federal- and state-related guidelines for Preferred’s offices; work on policies and procedures in existing states, adding new states upon expansion; oversee all CHAP policies; and work closely with Corporate Clinical Director Stephanie Kulak, among other duties.

Before joining Preferred in 2009, Murawski was an account manager for US Maintenance.  She joined Preferred as a client services coordinator and was soon promoted to client service manager of the Bala Cynwyd office in Pennsylvania.  In 2013, she became a regional director for Preferred’s Pennsylvania offices.

Yeurys Pujols, Hudson County Community College

The Hudson County Community College board of trustees approved the appointment of Yeurys Pujols to be the college’s inaugural vice president for diversity, equity and inclusion.

HCCC President Chris Reber recommended the appointment, in consultation with the board of trustees Executive Committee, based on Pujols’ leadership experience; support of the college’s nationally distinctive diversity, equity and inclusion initiatives; and feedback from many members of the college community.

Pujols is executive director of the HCCC North Hudson Campus. Born in the Dominican Republic, he moved to New Jersey at the age of 13. Pujols joined the college in 2006. After serving as counselor and history instructor, he was appointed director of enrollment and student services in 2010.

Alissa Van Volkom, TD Bank

TD Bank, America’s Most Convenient Bank, announced the appointment of Alissa Van Volkom as head of U.S. consumer deposits, products and payments. In this role, Van Volkom will lead all aspects of TD’s deposit products, including product development, business analytics, sales strategies and support, and customer experience and engagement.

“Alissa’s expertise and ability to drive product strategy and operations from an outside-in perspective make her uniquely well-positioned to drive growth, efficiency and profitability, while still keeping customer experience at the forefront,” said Matt Boss, head of consumer products for TD Bank.

Van Volkom joined TD in 2018 and previously served as the bank’s senior vice president, head of customer, product and digital marketing. In this role, she led the customer marketing strategy and developed integrated marketing plans to generate demand for TD’s consumer and commercial products across the U.S. bank. She also managed the U.S. digital marketing organization, where she championed the development of data-driven digital marketing strategies to create connected customer experiences.

Michael J. Willner, Curcio Mirzaian Sirot LLC

Curcio Mirzaian Sirot LLC has announced that Michael J. Willner has joined its law practice as a partner in the Community Association Law and Business Litigation practice areas.  He previously was a partner with Brill & Meisel in New York City.

With more than 17 years’ experience, Willner’s practice is focused on general condominium/cooperative law, commercial and residential real estate transactions and related litigation. He represents condominium and cooperative boards, individual unit owners, shareholders, purchasers and sellers, and landlords and tenants, providing them with general counsel services and litigating complex real estate disputes.

Willner is an experienced trial lawyer appearing regularly in courts throughout New Jersey and New York, as well as at mediation and arbitration hearings and ECB hearings. He has extensive experience with landlord-tenant law, zoning issues, mechanic’s liens, foreclosure actions, contract disputes, construction claims and other management issues. He also drafts license and construction agreements, real estate contracts, and indemnification agreements.

R. Scott Areglado, BrainsWay

BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced the appointment of R. Scott Areglado as senior vice president and chief financial officer.

“We are very pleased to announce that Scott Areglado has joined BrainsWay to become our senior vice president and chief financial officer,” stated Christopher von Jako, CEO and president of BrainsWay. “Scott’s appointment comes at a critically important time for our company, as we expand our commercial operations and take steps to accelerate the growth of our core business. Our progress in the market has enabled us to attract top talent across our organization, and Scott’s appointment will provide BrainsWay with seasoned leadership in financial operations and controls in order to help us execute on our corporate objectives.”

(Not pictured.)


iCIMS Inc., the talent cloud company, announced the appointments of Nancy Disman and Alessandra Yockelson to its board of directors. In their roles, Disman and Yockelson will provide strategic insight and counsel to support continuous innovation and operational excellence for iCIMS’ next phase of growth.

“We are thrilled to welcome Nancy and Alessandra to the iCIMS board of directors,” said Steve Lucas, CEO of iCIMS. “Their backgrounds and unique expertise bring invaluable diverse perspectives as we continue to grow and deliver innovative solutions to empower our customers to attract, engage, hire and advance their best talent.”

(Not pictured.)

NAI James E. Hanson

NAI James E. Hanson, the largest New Jersey-based full-service independent commercial real estate firm, announces the appointment of two new vice presidents with the promotions of Patrick Lennon and Christopher Todd.

Joining NAI James E. Hanson in 2013, Todd and Lennon have quickly established themselves as leaders in the highly competitive northern New Jersey commercial real estate brokerage community and valued team members at the Teterboro-based real estate firm. Through their tireless focus on professional development and deep involvement in complex sale and lease transactions across the region, Lennon and Todd have each gained a deep understanding of the real estate transaction process and their local submarkets that they leverage in their work each day.

(Not pictured.)

Thomas Nusbickel, CorMedix Inc.

CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced the appointment of Thomas Nusbickel to the newly created position of chief commercial officer. Nusbickel will be responsible for advancing the commercial strategy needed to bring DefenCath to patients in the U.S. when approved by FDA for commercial distribution.

Khoso Baluch, CEO of CorMedix, commented: “Tom represents a key addition to our executive team, as he brings decades of leadership experience in commercial strategy and highly relevant experience in the renal disease space. As we are eager to continue planning in preparation for our commercial launch of DefenCath, Tom will be well positioned to lead and strengthen the commercial effort for CorMedix.”

(Not pictured.)

Torben Ostergaard, Spinnaker Insurance Co.

Spinnaker Insurance Co., a national property and casualty insurer licensed in 50 states and rated A- (Excellent) by A.M. Best Co., wholly owned by Hippo Enterprises Inc., announced the appointment of Torben Ostergaard as its new CEO and president. Ostergaard joins Spinnaker after more than a decade in C-suite roles at insurance and financial services firm USAA. Dave Ingrey, who previously held the CEO position, will transition to chief operating officer and continue to play an integral role in shaping Spinnaker’s future.

Most recently a Fortune 100 executive, Ostergaard brings 25 years’ experience as a risk officer working across the financial services industry. At USAA, he served as executive vice president, chief risk officer and a member of the executive council that manages the day-to-day operations of the company, including property & casualty insurance, banking and life insurance. Prior to USAA, he was chief credit officer at HSBC Financial in Canada. He is currently serving on Opendoor’s risk advisory board.

(Not pictured.)

Frank L. Porfido, TYME Technologies Inc.

TYME Technologies Inc., an emerging biotechnology company developing cancer metabolism-based therapies, announced that it has appointed Frank L. Porfido as its chief financial officer.

Porfido is a well-established biotech and pharmaceutical industry executive with over 25 years of strategic financial leadership expertise. Throughout his career, Porfido has demonstrated a track record of building and leading cross-functional teams. Collectively, he spent over 15 years at Novartis in various leadership roles, including serving as the global head of finance for its Oncology Business Unit and head of global finance for its Oncology Translational Medicines Unit. He was responsible for developing its global strategic plan for a $15 billion business unit and, in his OTM position, he was a member of a leadership team that managed the early-stage Oncology pipeline.

(Not pictured.)